Eton Pharmaceuticals Announces FDA Approval of ZONISADE™ETON: Eton Pharmaceuticals
2022-07-18 07:05:00
Eton Pharmaceuticals Announces FDA Approval of ZONISADE™ (Zonisamide Oral Suspension)
0%
0%
0%
0%
0%
About Eton Pharmaceuticals, Inc
Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Sean E. Brynjelsen
Website
etonpharma.com
Headquarters
Deer Park
Employees
28
Founded
2017
ISIN
US29772L1089
Eton Pharmaceuticals, Inc. engages in the development, acquisition, and commercialization of prescription drug products. Its products include Biorphen, Alaway Preservative Free, zonisamide oral suspension, topiramate oral suspension, lamotrigine for oral suspension, cysteine injection, and ephedrine ready-to-use injection. The company was founded in April 2017 and is headquartered in Deer Park, IL.
FDA Approval of Cysteine Hydrochloride InjectionETON: Eton Pharmaceuticals
2022-04-11 07:30:00
Eton Pharmaceuticals Announces FDA Approval of Cysteine Hydrochloride Injection
Accumulation?So,the blue areas are selling areas. Every time the price one of those areas the price drops.
For every seller there needs to be a buyer. So then that red highlighted area is were shares are accumulated until there are no more sellers left. Price is reaching a monthly demand area. Who are the buyers
Eton Pharmaceuticals Announces FDA Approval of Rezipres® (EphedrETON: Eton Pharmaceuticals
2021-06-15 10:37:52
Eton Pharmaceuticals Announces FDA Approval of Rezipres® (Ephedrine Hydrochloride Injection)
$ETON Aug 10 PDUFA run upNYSE:BHC and NASDAQ:ETON has a PDUFA date of Aug 10.
Source: www.benzinga.com
Disclaimer: Just an idea. Not recommending to buy or sell.
See all ideas
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
